Recombinant Mouse IL-10, Tag Free
Interleukin 10, also known as cytokine synthesis inhibitory factor (CSIF), is the charter member of the IL-10 family of alpha -helical cytokines that also includes IL-19, IL-20, IL-22, and IL-24 [1, 2]. IL-10 is secreted by many activated hematopoietic cell types as well as hepatic stellate cells, keratinocytes, and placental cytotrophoblasts [2-5]. Mature mouse IL-10 shares 85% amino acid sequence identity with rat and 70%-77% with bovine, canine, equine, feline, human, ovine, and porcine IL-10. Whereas human IL-10 is active on mouse cells, mouse IL-10 does not act on human cells [6, 7]. IL-10 is a 178 amino acid molecule that contains two intrachain disulfide bridges and is expressed as a 36 kDa noncovalently associated homodimer [8-10]. The IL-10 dimer binds to two IL-10 R alpha /IL-10 R1 chains, resulting in recruitment of two IL-10 R beta /IL-10 R2 chains and activation of a signaling cascade involving JAK1, TYK2, and STAT3 [11]. IL-10 R beta does not bind IL-10 by itself but is required for signal transduction [1]. IL-10 R beta also associates with IL-20 R alpha, IL-22 R alpha, or IL-28 R alpha to form the receptor complexes for IL-22, IL-26, IL-28, and IL-29 [12-14]. IL-10 is a critical molecule in the control of viral infections and allergic and autoimmune inflammation [15-17]. It promotes phagocytic uptake and Th2 responses but suppresses antigen presentation and Th1 proinflammatory responses [2].
Reference
[1]. Pestka, S. et al. (2004) Annu. Rev. Immunol. 22:929.
[2]. O’Garra, A. and P. Vieira (2007) Nat. Rev. Immunol. 7:425.
[3]. Mathurin, P. et al. (2002) Am. J. Physiol. Gastrointest. Liver Physiol. 282:G981.
[4]. Grewe, M. et al. (1995) J. Invest. Dermatol. 104:3.
[5]. Szony, B.J. et al. (1999) Mol. Hum. Reprod. 5:1059.
[6]. Vieira, P. et al. (1991) Proc. Natl. Acad. Sci. 88:1172.
[7]. Hsu, D.-H. et al. (1990) Science 250:830.
[8]. Moore, K. et al. (1990) Science 248:1230.
[9]. Windsor, W.T. et al. (1993) Biochemistry 32:8807.
[10]. Syto, R. et al. (1998) Biochemistry 37:16943.
[11]. Kotenko, S.V. et al. (1997) EMBO J. 16:5894.
[12]. Kotenko, S.V. et al. (2000) J. Biol. Chem. 276:2725.
[13]. Hor, S. et al. (2004) J. Biol. Chem. 279:33343.
[14]. Sheppard, P. et al. (2003) Nat. Immunol. 4:63.
[15]. Fitzgerald, D.C. et al. (2007) Nat. Immunol. 8:1372.
[16]. Wu, K. et al. (2007) Cell. Mol. Immunol. 4:269.
[17]. Blackburn, S.D. and E.J. Wherry (2007) Trends Microbiol. 15:143.
Accession # |
P18893 |
Alternate Names |
IL10; IL-10; IL10A; IL-10MGC126451; interleukin 10; interleukin-10; TGIF |
Source |
Human embryonic kidney cell, HEK293-derived mouse IL-10 protein |
Protein sequence |
Ser19-Ser178 |
M.Wt |
18.8 kDa |
Appearance |
Solution protein |
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -7°C as supplied. |
Concentration |
0. 2 mg/mL |
Formulation |
Dissolved in sterile PBS buffer. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers. |
Biological Activity |
The EC50 for this effect is 0.01-0.1 ng/mL. Measured in a cell proliferation assay using MC/9-2 mouse mast cells. |
Shipping Condition |
Shipping with dry ice. |
Handling |
Centrifuge the vial prior to opening. |
Usage |
For Research Use Only! Not to be used in humans. |
Quality Control & DataSheet
- View current batch:
-
Purity > 95%, determined by SDS-PAGE.
- Datasheet
Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.